Cas12a Platform Enables Large-Scale Yeast Gene Screens
Researchers benchmark dCas12a-based CRISPR interference and activation tools for pooled screening in the yeast Yarrowia lipolytica.
Updated on Nov. 13, 2026 in Life Sciences

Researchers compared two Cas12a effectors across single-gene assays and a pooled CRISPR interference library in Yarrowia lipolytica, and found dLbCas12a produced more consistent and stronger late-stage depletion across targets than denAsCas12a. The team also tested an engineered variant, dHyperLbCas12a, for interference and activation phenotypes.
Why it matters
Cas12a adds a complementary platform with a T-rich PAM that can expand access to promoter regions and support multiplexed gene regulation. Efficient pooled screening tools in an industrially used yeast could speed functional genomics work across the field.
The pooled screen covered 752 crRNAs across nine essential or conditionally essential genes, with 18-nt spacers outperforming 20-, 23- and 25-nt variants. The effective targeting window was reported at roughly -260 to +50 bp around the transcription start site, and the study does not say how these design rules transfer to other host organisms.
The players
Yarrowia lipolytica
A yeast species widely used in industrial biotechnology for producing enzymes, lipids and other compounds, and a common model for metabolic engineering research.
The details
The researchers compared dLbCas12a and denAsCas12a in single-gene assays and a pooled CRISPR interference library, then ran enrichment-based CRISPR interference and activation screens that recovered expected drug-resistance and lipid-associated phenotypes. Highly active guide RNAs were enriched near transcription start sites, and intermediate GC content was associated with higher efficacy, with spacer length showing the strongest link to performance.
Timeline
• The study was posted as a bioRxiv preprint dated November 11, 2026.
Deeper Dive
The work builds on the growing use of Cas12a alternatives to Cas9, whose T-rich PAM requirement opens promoter regions that Cas9 often cannot reach. Demonstrating pooled screening in Yarrowia lipolytica extends these tools from model organisms into an industrially important yeast.
Because dHyperLbCas12a is positioned for large-scale gain- and loss-of-function screens, the platform could eventually let labs test many gene targets in one experiment. Any commercial or research use would depend on how well the approach generalizes beyond the single yeast species studied.
The takeaway
Pooled CRISPR screens depend heavily on guide RNA design, and this study points to 18-nt spacers and sites near transcription start sites as practical starting rules. Researchers planning similar screens should test these parameters in their own organism before assuming they hold.
Further reading
Explore more research on Life Sciences to see how gene regulation tools are being applied across organisms.
Source note: This article includes information reported by Biorxiv.







